Financhill
Sell
41

PFE Quote, Financials, Valuation and Earnings

Last price:
$25.04
Seasonality move :
1.54%
Day range:
$24.83 - $25.34
52-week range:
$20.92 - $27.69
Dividend yield:
6.91%
P/E ratio:
14.50x
P/S ratio:
2.26x
P/B ratio:
1.52x
Volume:
43.7M
Avg. volume:
62M
1-year change:
-6.85%
Market cap:
$141.5B
Revenue:
$63.6B
EPS (TTM):
$1.72

Earnings Data

Next earnings date for PFE
Feb 03
2026
Most recent earnings per share
$0.62
Missed by $0.01
(Nov 4/2025)
Consensus Estimate
$0.63
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PFE Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/03/2026 Q4 $16.9B -- -- $0.56 --
11/04/2025 Q3 $16.5B $16.7B $0.62 $0.63 -$0.01
08/05/2025 Q2 $13.5B $14.7B $0.51 $0.57 -$0.07
04/29/2025 Q1 $14.1B $13.7B $0.52 $0.67 -$0.15
02/04/2025 Q4 $17.3B $17.8B $0.07 $0.46 -$0.39
10/29/2024 Q3 $14.9B $17.7B $0.78 $0.61 $0.17
07/30/2024 Q2 $13B $13.3B $0.00 $0.46 -$0.46
05/01/2024 Q1 $13.9B $14.9B $0.55 $0.51 $0.04
01/30/2024 Q4 $14.4B $14.6B -$0.59 -$0.18 -$0.41
10/31/2023 Q3 -- $13.5B -$0.42 -- --
08/01/2023 Q2 -- $13B $0.41 -- --
05/02/2023 Q1 -- $18.5B $0.97 -- --
01/31/2023 Q4 -- $24.3B $0.87 -- --
11/01/2022 Q3 -- $22.6B $1.51 -- --
07/28/2022 Q2 -- $27.7B $1.73 -- --
05/03/2022 Q1 -- $25.7B $1.37 -- --
02/08/2022 Q4 -- $23.8B $0.59 -- --
11/02/2021 Q3 -- $24B $1.43 -- --
07/28/2021 Q2 -- $18.9B $1.02 -- --
05/04/2021 Q1 -- $14.5B $0.86 -- --
02/02/2021 Q4 -- $11.6B $0.15 -- --
10/27/2020 Q3 -- $10.3B $0.26 -- --
07/28/2020 Q2 -- $9.9B $0.62 -- --
04/28/2020 Q1 -- $10.1B $0.60 -- --
01/28/2020 Q4 -- $12.7B -$0.06 -- --
10/29/2019 Q3 -- $12.7B $1.36 -- --
07/30/2019 Q2 -- $13.3B $0.89 -- --
04/30/2019 Q1 -- $13.1B $0.68 -- --
01/29/2019 Q4 -- $14B -$0.07 -- --
10/30/2018 Q3 -- $13.3B $0.69 -- --
07/31/2018 Q2 -- $13.5B $0.65 -- --
05/01/2018 Q1 -- $12.9B $0.59 -- --
01/30/2018 Q4 -- $13.7B $2.02 -- --
10/31/2017 Q3 -- $13.2B $0.47 -- --
08/01/2017 Q2 -- $12.9B $0.51 -- --
05/02/2017 Q1 -- $12.8B $0.51 -- --
01/31/2017 Q4 -- $13.6B $0.13 -- --
11/01/2016 Q3 -- $13B $0.22 -- --
08/02/2016 Q2 -- $13.1B $0.33 -- --
05/03/2016 Q1 -- $13B $0.49 -- --
02/02/2016 Q4 -- $14B -$0.03 -- --

Pfizer Inc. Earnings Questions

  • How Much did Pfizer Inc. Generate in Revenue Last Quarter?

    Pfizer Inc. reported $16.7B worth of top line sales in its most recent quarter.

  • Did Pfizer Inc. Beat Earnings Last Quarter?

    Pfizer Inc. announced earnings per share of $0.62 which represents a miss of analyst forecast a $0.63 per share.

  • Is Pfizer Inc. Profitable?

    Pfizer Inc. reported $11.2B that represents $1.96 per share over the last quarter.

  • What is the Analyst Consensus for Pfizer Inc. EPS Next Year?

    Pfizer Inc.'s earnings are forecast to grow from $1.41 per share to $2.93 per share next year representing an increase of 121.45%.

  • When is Pfizer Inc.'s Earnings Date?

    Pfizer Inc.'s next earnings date is February 3, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock